Detalhe da pesquisa
1.
Real world challenges and disparities in the systemic treatment of ovarian cancer.
Gynecol Oncol
; 185: 180-185, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38442493
2.
Molecular profiling of gestational trophoblastic neoplasia: Identifying therapeutic targets.
Gynecol Oncol
; 184: 111-116, 2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38301309
3.
High-dose ascorbate exerts anti-tumor activities and improves inhibitory effect of carboplatin through the pro-oxidant function pathway in uterine serous carcinoma cell lines.
Gynecol Oncol
; 183: 93-102, 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38555710
4.
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials.
Gynecol Oncol
; 183: 103-114, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593674
5.
Role of endometrial sampling to differentiate between advanced endometrial versus ovarian malignancy: retrospective cohort study.
Int J Gynecol Cancer
; 34(4): 528-534, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38336373
6.
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial.
Lancet
; 399(10324): 541-553, 2022 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123694
7.
Molecular testing for endometrial cancer: An SGO clinical practice statement.
Gynecol Oncol
; 168: 48-55, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399812
8.
Understanding the spectrum of malignant bowel obstructions in gynecologic cancers and the application of the Henry score.
Gynecol Oncol
; 174: 114-120, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37182431
9.
High-fat diet and obesity are associated with differential angiogenic gene expression in epithelial ovarian cancer.
Gynecol Oncol
; 179: 97-105, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37956617
10.
Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women.
Gynecol Oncol
; 177: 38-45, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37634258
11.
The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study.
Gynecol Oncol
; 173: 130-137, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37148580
12.
Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.
Gynecol Oncol
; 174: 213-223, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37229879
13.
A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial.
Gynecol Oncol
; 167(3): 423-428, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36244829
14.
What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer.
Gynecol Oncol
; 166(3): 410-416, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35835612
15.
Transfusion Requirements with Hybrid Management of Placenta Accreta Spectrum Incorporating Targeted Embolization and a Selective Use of Delayed Hysterectomy.
Am J Perinatol
; 29(14): 1503-1513, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973741
16.
Real-world treatment patterns of maintenance therapy in platinum-sensitive recurrent ovarian cancer.
Gynecol Oncol
; 163(1): 50-56, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34301411
17.
The preferences of women with ovarian cancer for oral versus intravenous recurrence regimens.
Gynecol Oncol
; 162(2): 440-446, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34053748
18.
Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC).
Gynecol Oncol
; 161(2): 382-388, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33712274
19.
Utilizing an interim futility analysis of the OVAL study (VB-111-701/GOG 3018) for potential reduction of risk: A phase III, double blind, randomized controlled trial of ofranergene obadenovec (VB-111) and weekly paclitaxel in patients with platinum resistant ovarian cancer.
Gynecol Oncol
; 161(2): 496-501, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33637348
20.
Obesity and altered angiogenic-related gene expression in endometrial cancer.
Gynecol Oncol
; 163(2): 320-326, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34538531